Cargando…
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a chronic disease characterized by a progressive elevation in mean pulmonary arterial pressure. This occurs due to abnormal remodeling of small peripheral lung vasculature resulting in progressive occlusion of the artery lumen that eventually causes right hea...
Autores principales: | Orriols, Mar, Gomez-Puerto, Maria Catalina, ten Dijke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501910/ https://www.ncbi.nlm.nih.gov/pubmed/28447104 http://dx.doi.org/10.1007/s00018-017-2510-4 |
Ejemplares similares
-
Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension
por: Gomez‐Puerto, Maria Catalina, et al.
Publicado: (2019) -
MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension
por: Gomez-Puerto, Maria Catalina, et al.
Publicado: (2020) -
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling
por: Hurst, Liam A., et al.
Publicado: (2017) -
Imaging the TGFβ type I receptor in pulmonary arterial hypertension
por: Rotteveel, Lonneke, et al.
Publicado: (2023) -
The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
por: Ormiston, Mark L., et al.
Publicado: (2015)